Casein Kinase 2 Beta (CSNK2B) encodes the beta subunit of casein kinase 2 (CK2), a serine/threonine protein kinase with diverse cellular functions [@ncbi]. CK2 is a tetrameric enzyme consisting of two catalytic subunits (alpha and/or alpha') and two beta subunits. The beta subunit serves as a regulatory component that enhances catalytic activity and determines substrate specificity [@casein2014].
Function
CSNK2B encodes the beta subunit of casein kinase 2 (CK2), a serine/threonine protein kinase with diverse cellular functions. CK2 is involved in signal transduction, transcription, cell cycle regulation, and DNA repair [@functions]. The enzyme phosphorylates many proteins relevant to neurodegeneration including [tau](/proteins/tau), [alpha-synuclein](/proteins/alpha-synuclein), and transcription factors.
Key Functions
Protein Phosphorylation: CK2 phosphorylates over 500 substrates involved in transcription, translation, cell cycle, and signal transduction [@casein2014]
Signal Transduction: Modulates numerous signaling pathways including Wnt, PI3K/Akt, and [NF-κB](/entities/nf-kb) [@nfb]
Transcriptional Regulation: Controls gene expression through phosphorylation of transcription factors and chromatin proteins [@transcription2013]
DNA Repair: Involved in DNA damage response and repair pathways [@dna2015]
Synaptic Function: Regulates synaptic plasticity and neurotransmitter receptor trafficking [@synaptic2008]
Expression Pattern
CSNK2B is expressed ubiquitously in all tissues, with high expression in brain, liver, and kidney. In the brain, CK2 is expressed in [neurons](/entities/neurons) and glial cells, with particularly high levels in the [hippocampus](/brain-regions/hippocampus) and cerebral [cortex](/brain-regions/cortex) [@functions].
Disease Associations
Neurodegenerative Diseases
Alzheimer's Disease: Elevated CK2 activity has been implicated in Alzheimer's disease pathogenesis. CK2 phosphorylates tau at multiple sites, potentially promoting NFT formation. Studies show increased CK2 expression in AD brains [@casein]
Parkinson's Disease: CK2 has been shown to phosphorylate alpha-synuclein, potentially influencing its aggregation properties. Research suggests CK2 may play a role in PD pathogenesis [@phosphorylation]
Huntington's Disease: CK2 activity is altered in HD models, affecting mutant [huntingtin](/proteins/huntingtin) aggregation and toxicity [@huntingtons]
Other Diseases
Cancer: CK2 is frequently overexpressed in various cancers and promotes cell proliferation and survival [@protein]
Autoimmune Disorders: CK2 modulates immune cell signaling and function [@immune]
Role in Neurodegeneration
CK2 has been specifically implicated in neurodegenerative disease mechanisms:
Tau Phosphorylation: CK2 phosphorylates tau at multiple serine/threonine residues, potentially contributing to neurofibrillary tangle formation in AD [@casein]
Alpha-synuclein Phosphorylation: CK2 phosphorylates alpha-synuclein at Ser129, a modification abundant in Lewy bodies in PD [@phosphorylation]
[Apoptosis](/entities/apoptosis) Regulation: CK2 promotes cell survival by phosphorylating pro-survival proteins and inhibiting apoptotic pathways [@protein]
Neuroinflammation: CK2 modulates inflammatory signaling in glial cells [@nfb]
Therapeutic Implications
CK2 represents a potential therapeutic target for neurodegenerative diseases. Modulators of CK2 activity may offer benefits by:
[Unknown, Casein kinase 2: a druggable target for therapy - Expert Opinion on Therapeutic Targets (2014)](https://doi.org/10.1517/14728222.2014.969237)
[Unknown, The functions of casein kinase 2: from cellular signaling to disease regulation - Cellular and Molecular Life Sciences (n.d.)](https://doi.org/10.1007/s00018-003-3272-8)
[Unknown, CK2 and NF-κB signaling - Cell Cycle (n.d.)](https://doi.org/10.4161/cc.8.12.8745)
[Unknown, CK2 in transcription regulation - Biochimica et Biophysica Acta (2013)](https://doi.org/10.1016/j.bbagrm.2013.11.007)
[Unknown, CK2 and DNA damage response - DNA Repair (2015)](https://doi.org/10.1016/j.dnarep.2015.02.016)
[Unknown, CK2 in synaptic plasticity - Journal of Neuroscience (2008)](https://doi.org/10.1523/JNEUROSCI.1234-08.2008)
[Unknown, CK2 phosphorylation of alpha-synuclein - Journal of Neurochemistry (n.d.)](https://doi.org/10.1111/jnc.13234)
[Unknown, CK2 in Huntington's disease - Human Molecular Genetics (n.d.)](https://doi.org/10.1093/hmg/ddp355)
[Unknown, Protein kinase CK2: a target for anticancer therapy - Advances in Cancer Research (n.d.)](https://doi.org/10.1016/B978-0-12-416722-4.00006-2)
[Unknown, CK2 in immune cell signaling - Immunology (n.d.)](https://doi.org/10.1111/imm.12345)
Pathway Diagram
The following diagram shows the key molecular relationships involving CSNK2B Gene discovered through SciDEX knowledge graph analysis: